RAD18 contributes to the migration and invasion of human cervical cancer cells via the interleukin1ß pathway.
Mol Med Rep
; 20(4): 3415-3423, 2019 Oct.
Article
em En
| MEDLINE
| ID: mdl-31432163
ABSTRACT
The E3 ubiquitin ligase RAD18 has been identified as an oncoprotein that exhibits prometastatic properties in various types of cancer; however, the role of RAD18 in cervical cancer (CC) remains unclear. In the present study, it was revealed that increased expression of RAD18 was associated with worse prognosis of patients with CC. Knockdown of endogenous RAD18 suppressed the motility and invasiveness of CC cells, as evaluated by Transwell assays. mRNA sequencing revealed that silencing RAD18 altered the expression profile of proinflammatory mediators, such as interleukin1ß (IL1ß). Furthermore, exogenous IL1ß treatment rescued RAD18mediated CC cell invasion. These findings indicated an underlying mechanism via which RAD18 promotes CC progression, suggesting that RAD18 may be a potential biomarker and therapeutic target for malignant CC.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Transdução de Sinais
/
Movimento Celular
/
Neoplasias do Colo do Útero
/
Ubiquitina-Proteína Ligases
/
Proteínas de Ligação a DNA
/
Interleucina-1beta
/
Proteínas de Neoplasias
Tipo de estudo:
Prognostic_studies
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Mol Med Rep
Ano de publicação:
2019
Tipo de documento:
Article